Two Sigma Advisers LP Has $3,715,000 Position in Amedisys Inc (AMED)

Two Sigma Advisers LP decreased its stake in shares of Amedisys Inc (NASDAQ:AMED) by 14.5% during the third quarter, Holdings Channel reports. The fund owned 78,318 shares of the company’s stock after selling 13,300 shares during the period. Two Sigma Advisers LP owned 0.23% of Amedisys worth $3,715,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Sheaff Brock Investment Advisors LLC acquired a new stake in Amedisys during the second quarter valued at about $1,058,000. Gerstein Fisher raised its stake in Amedisys by 27.7% in the second quarter. Gerstein Fisher now owns 91,288 shares of the company’s stock valued at $4,608,000 after buying an additional 19,798 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Amedisys by 404.0% in the second quarter. JPMorgan Chase & Co. now owns 26,499 shares of the company’s stock valued at $1,338,000 after buying an additional 21,241 shares during the last quarter. Teacher Retirement System of Texas raised its stake in Amedisys by 21.6% in the second quarter. Teacher Retirement System of Texas now owns 3,780 shares of the company’s stock valued at $191,000 after buying an additional 672 shares during the last quarter. Finally, Principal Financial Group Inc. raised its stake in Amedisys by 1.2% in the second quarter. Principal Financial Group Inc. now owns 204,321 shares of the company’s stock valued at $10,314,000 after buying an additional 2,519 shares during the last quarter. Institutional investors and hedge funds own 93.61% of the company’s stock.

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Amedisys Inc (NASDAQ:AMED) traded up 0.41% during trading on Friday, reaching $46.52. 179,782 shares of the company were exchanged. Amedisys Inc has a 1-year low of $34.58 and a 1-year high of $55.16. The company’s 50-day moving average price is $44.98 and its 200-day moving average price is $45.37. The stock has a market capitalization of $1.56 billion, a P/E ratio of 37.94 and a beta of 1.43.

WARNING: “Two Sigma Advisers LP Has $3,715,000 Position in Amedisys Inc (AMED)” was originally posted by sleekmoney and is owned by of sleekmoney. If you are viewing this story on another domain, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this story can be viewed at http://sleekmoney.com/two-sigma-advisers-lp-has-3715000-position-in-amedisys-inc-amed/1656099.html.

AMED has been the subject of several analyst reports. Zacks Investment Research lowered shares of Amedisys from a “hold” rating to a “sell” rating in a research report on Tuesday, November 1st. Jefferies Group LLC restated a “buy” rating and set a $50.00 price target (down from $59.00) on shares of Amedisys in a research report on Tuesday, November 1st. Mizuho upgraded shares of Amedisys from a “neutral” rating to a “buy” rating and set a $47.00 target price for the company in a report on Friday, November 4th. They noted that the move was a valuation call. Craig Hallum began coverage on shares of Amedisys in a report on Friday, December 16th. They set a “buy” rating and a $48.00 target price for the company. Finally, Benchmark Co. began coverage on shares of Amedisys in a report on Friday, January 27th. They set a “hold” rating and a $50.00 target price for the company. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $52.88.

About Amedisys

Amedisys, Inc (Amedisys) is a provider of home health and hospice services. The Company offers home health services to the chronic, co-morbid, aging American population. The Company operates through three segments: home health, hospice and personal care. The Company’s home health segment delivers a range of services in the homes of individuals recovering from surgery, have a chronic disability or terminal illness or need assistance with completing important personal tasks.

5 Day Chart for NASDAQ:AMED

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/two-sigma-advisers-lp-has-3715000-position-in-amedisys-inc-amed/1656099.html

Receive News & Ratings for Amedisys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *